Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age

PHASE3CompletedINTERVENTIONAL
Enrollment

466

Participants

Timeline

Start Date

January 5, 2009

Primary Completion Date

November 2, 2009

Study Completion Date

November 2, 2009

Conditions
Infections, Streptococcal
Interventions
BIOLOGICAL

Pneumococcal conjugate vaccine GSK1024850A (different lots)

Intramuscular injection, 3 doses

BIOLOGICAL

Infanrix hexa

Intramuscular injection, 3 doses in Malaysia and 2 doses in Singapore

BIOLOGICAL

Infanrix-IPV/Hib

Intramuscular injection, only for Visit 2 in Singapore

BIOLOGICAL

Rotarix

Oral, 2 doses

Trial Locations (5)

59100

GSK Investigational Site, Kuala Lumpur

70300

GSK Investigational Site, Seremban, Negeri Sembilan

119074

GSK Investigational Site, Singapore

149547

GSK Investigational Site, Singapore

229899

GSK Investigational Site, Singapore

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY